WIXOM, MICH.—Shares of Rockwell Medical Technology Inc. began trading January 5 on the Nasdaq Global Market, according to a company news release.
The Nasdaq Global Market accepted Rockwell’s application dec. 29, 2006; Rockwell’s shares will continue to be traded under the same ticker symbol, RMTI. Rockwell manufactures and develops concentrates and specialty pharmaceuticals for dialysis patients.
“The Nasdaq Global Market sets higher requirements of stockholder’s equity, net income and market value,” Rockwell’s President and CEO Robert Chioini said in a statement. “We believe this move to global market will increase our visibility and credibility in the institutional marketplace and increase the attractiveness of Rockwell shares to potential new investors.”
The Nasdaq Global Market has more than 1,450 companies that must meet financial and liquidity requirements in order to be listed on the market. Rockwell medical had been trading on the smaller Nasdaq capital market since 1996. as of January 3, the company has a market capitalization of approximately $82 million, according to Rockwell.
